Dr. Elizabeth M. Billingsley, MD

Dr. Billingsley practices at Penn State Health Milton S. Hershey Medical Center in Hershey, Pennsylvania, part of Penn State.

Dr. Billingsley's NPI, 1093779340, was assigned on April 13, 2006. Dr. Billingsley graduated from Penn State College of Medicine in 1989. Dr. Billingsley holds Pennsylvania license MD047708L.

Dr. Billingsley's primary practice is Penn State Health Milton S. Hershey Medical Center, at 500 University Drive, Hershey, PA 17033 in Dauphin County. The practice phone is (717) 531-8521.

Dr. Billingsley's primary practice is Penn State Health Milton S. Hershey Medical Center in Hershey, Pennsylvania, part of Penn State. The medical group on file is Penn State Health Milton S. Hershey Medical Center. Dmand AI also links Dr. Billingsley to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Billingsley practices. Vendor and product names are available with a free account.

Dermatology is Dr. Billingsley's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Billingsley is board certified in dermatology by the American Board of Dermatology. Dr. Billingsley is licensed in Pennsylvania.

Dmand AI lists cancerous skin growth removal among the conditions Dr. Billingsley treats.

CMS data shows 349 Medicare services from Dr. Billingsley across 7 procedure codes in 2024, for 146 Medicare patients. Medicare paid $49,672 for them. Every service was in an office.

CMS counts 146 Medicare patients who saw Dr. Billingsley in 2024. The largest group is 65 to 74, with 61 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Billingsley's median patient age at 76, with 48% women.

In 2024, Dr. Billingsley wrote 56 Medicare Part D claims for 21 patients. 86% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $43 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Billingsley for performance year 2024, reported as part of a group. Dr. Billingsley accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 36 procedures of melanoma (skin cancer) excision by Dr. Billingsley, more than 83% of the clinicians it reports for that procedure.

Dmand AI links 62 papers to Dr. Billingsley, published from 2008 to 2025. 2019 was the busiest year, with 7. The most frequent topics are Skin Neoplasms, Carcinoma, Basal Cell and Mohs Surgery. Dr. Billingsley has published most often in Dermatol Surg. Dr. Billingsley's most frequent co-authors are Charlene Lam, MD, Thomas Stasko, MD and Yesul Kim, MD.

Dmand AI links Dr. Billingsley to 2 clinical trials. Conditions studied include Basal Cell Nevus Syndrome, Carcinoma, Basal Cell and Jaw Cysts. Open Payments lists research payments to Dr. Billingsley that name 1 trial.

CMS Open Payments shows 37 general payments to Dr. Billingsley from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 90% of the total. LEO Pharma Inc. paid the most, $17,447. It also lists 9 research payments totaling $1,331 in 2025, naming 1 clinical trial.

Dmand AI lists 2 awards for Dr. Billingsley, most recently Regional Top Doctor in 2014.

Dr. Billingsley graduated from Penn State College of Medicine in 1989. Dr. Billingsley is a member of AAD.

Dr. Billingsley is in network with 18 carriers, including Elevance, Excellus BlueCross BlueShield and HCSC. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.